Endothelial progenitor cells predict long-term prognosis in patients with stable angina treated with percutaneous coronary intervention - Five-year follow-up of the PROCREATION study

Circulation Journal

Volumn 77, Issue 7, 2013, Pages 1728-1735

  Pelliccia, Francesco ^a   Pasceri, Vincenzo ^b   Rosano, Giuseppe ^c   Pristipino, Christian ^b   Roncella, Adriana ^b   Speciale, Giulio ^b   Pannarale, Giuseppe ^a   Schiariti, Michele ^a   Greco, Cesare ^a   Gaudio, Carlo ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d Eleonora Lorillard Spencer Cenci Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CD133 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CLOPIDOGREL; ENDOGLIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BLEEDING; CARCINOMA; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL PROGENITOR CELL; FEMALE; FEMUR FRACTURE; FLOW CYTOMETRY; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; LOADING DRUG DOSE; LONG TERM SURVIVAL; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; STABLE ANGINA PECTORIS; TREATMENT OUTCOME;

AGED; ANGINA, STABLE; ANTIGENS, DIFFERENTIATION; DISEASE-FREE SURVIVAL; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STEM CELLS; SURVIVAL RATE; TIME FACTORS;

EID: 84879344363     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1608     Document Type: Article

References (35)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-1169.
3. Aburakawa Y, Kawabe JI, Okada M, Yamauchi A, Asanome A, Kabara M, et al. Prostacyclin stimulated integrin-dependent angiogenic effects of endothelial progenitor cells and mediated potent circulation recovery in ischemic hind limb model. Circ J 2013; 77: 1053-1062.
4. Moon JH, Chae MK, Kim KJ, Kim HM, Cha BS, Lee HC, et al. Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease. Circ J 2012; 76: 2273-2279.
5. Ying Y, Yang K, Liu Y, Chen QJ, Shen WF, Lu L, et al. 5A uremic solute, P-cresol, inhibits the proliferation of endothelial progenitor cells via the p38 pathway. Circ J 2011; 75: 2252-2259.
6. Nakanishi C, Nagaya N, Ohnishi S, Yamahara K, Takabatake S, Konno T, et al. Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow. Circ J 2011; 75: 2260-2268.
7. Eizawa T, Ikeda U, Murakami Y, Matsui K, Yoshioka T, Suzuki C, et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart 2004; 90: 685-686.
8. Güven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006; 48: 1579-1587.
9. Werner N, Kosiol S, Schiegl T. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
10. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
11. Leor J, Marber M. Endothelial progenitors: A new tower of Babel? J Am Coll Cardiol 2006; 48: 1588-1590.
12. Pelliccia F, Cianfrocca C, Rosano G, Mercuro G, Speciale G, Pasceri V. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: A prospective study. JACC Cardiovasc Interv 2010; 3: 78-86.
13. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry: International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5: 213-226.
14. Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A, et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006; 27: 2247-2255.
15. Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 2003; 101: 168-172.
16. Wang Y, Johnsen HE, Mortensen S, Bindslev L, Ripa RS, Haack-Sørensen M, et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2006; 92: 768-774.
17. Sieveking DP, Buckle A, Celermajer DS, Ng MK. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: Insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008; 51: 660-668.
18. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau. Atherosclerosis 2008; 197: 496-503.
19. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004; 24: 288-293.
20. Wassmann S, Werner N, Czech T, Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 2006; 99: e74-e83.
21. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis: Results from a large population-based study. PLoS ONE 2007; 2: e975-e980.
22. Rogacev KS, Ziegelin M, Ulrich C, Seiler S, Girndt M, Fliser D, et al. Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome. Nephrol Dial Transplant 2009; 24: 3480-3486.
23. Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, et al. CD14++CD16+ monocytes independently predict cardiovascular events: A cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 2012; 60: 1512-1520.
24. Van Craenenbroeck EM, Vrints CJ, Haine SE, Vermeulen K, Goovaerts I, Van Tendeloo VF, et al. A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile. J Appl Physiol 2008; 104: 1006-1013.
25. Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: Impact on restenosis. Circulation 2007; 115: 553-561.
26. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
27. George J, Herz I, Goldstein E, Abashidze S, Deutch V, Shmilovich H, et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 2003; 23: e57-e60.
28. Inoue T, Croce K, Morooka T, Sakuma M, Node K, Simon DI. Vascular inflammation and repair: Implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Interv 2011; 4: 1057-1066.
29. Numaguchi Y, Sone T, Okumura K, Ishii M, Morita Y, Kubota R, et al. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 2006; 114 (1 Suppl): 114-119.
30. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, et al. Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002; 105: 3017-3024.
31. Wang TJ, Yang YJ, Xu B, Zhang Q, Jin C, Tang Y, et al. Atorvastatin accelerates both neointimal coverage and re-endothelialization after sirolimus-eluting stent implantation in a porcine model: New findings from optical coherence tomography and pathology. Circ J 2012; 76: 2561-2571.
32. França CN, Pinheiro LF, Izar MC, Brunialti MK, Salomão R, Bianco HT, et al. Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease. Circ J 2012; 76: 729-736.
33. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, et al. Evidence for importance of angiotensin II type 1 receptor in ischemia induced angiogenesis. J Clin Invest 2002; 109: 603-611.
34. Li P, Kondo T, Numaguchi Y, Kobayashi K, Aoki M, Inoue N, et al. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril induced angiogenesis. Hypertension 2008; 51: 252-258.
35. Pelliccia F, Pasceri V, Cianfrocca C, Vitale C, Speciale G, Gaudio C, et al. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: A randomized, double-blind, placebo-controlled study. Atherosclerosis 2010; 210: 510-515.